menu
    • menu

    Company profile for Regen BioPharma

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP) focused on the immunology and immunotherapy space. The Company plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is advancing small molecule therapies for treating cancer and autoimmune disorders by modulating the Checkpoint NR2F6. The company also developing ...
    Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP) focused on the immunology and immunotherapy space. The Company plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is advancing small molecule therapies for treating cancer and autoimmune disorders by modulating the Checkpoint NR2F6. The company also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Regen BioPharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4700 Spring Street, Suite 304 La Mesa, CA 91942
    Telephone
    Telephone
    (619) 722-5505
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.regenbiopharmainc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Regen Biopharma To Present Hemaxellerate Orphan Drug Update
    Regen Biopharma To Present Hemaxellerate Orphan Drug Update

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154642/0/en/Regen-BioPharma-Update-on-Orphan-Drug-Application-for-HemaXellerate-Will-Be-Presented-At-Emerging-Growth-Conference-on-September-24-2025.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    Regen Bio FDA Response For Orphan Drug App For HemaXellerate
    Regen Bio FDA Response For Orphan Drug App For HemaXellerate

    16 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/16/3150748/0/en/Regen-BioPharma-Prepares-Response-For-FDA-Regarding-Its-Orphan-Drug-Application-for-HemaXellerate.html

    GLOBENEWSWIRE
    16 Sep 2025
    Share Share
    Regen BioPharma Explores HemaXellerate Expansion
    Regen BioPharma Explores HemaXellerate Expansion

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144467/0/en/Regen-BioPharma-Explores-Expanded-Use-of-HemaXellerate-for-Chemotherapy-Induced-Bone-Marrow-Suppression.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Regen Bio Explores HemaXellerate's Impact on Chemotherapy Market
    Regen Bio Explores HemaXellerate's Impact on Chemotherapy Market

    15 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/15/3134254/0/en/Regen-BioPharma-Discusses-Potential-Impact-of-HemaXellerate-on-Chemotherapy-Treament-Market.html

    GLOBENEWSWIRE
    15 Aug 2025
    Share Share
    Regen BioPharma to Pursue Orphan Drug Status for Lead Product
    Regen BioPharma to Pursue Orphan Drug Status for Lead Product

    23 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/23/3120196/0/en/Regen-BioPharma-Inc-to-Seek-Orphan-Drug-Designation-for-Lead-Product.html

    GLOBENEWSWIRE
    23 Jul 2025
    Share Share
    Regen BioPharma Expands Vision For HemaXellerate™ Phase 1 Trial
    Regen BioPharma Expands Vision For HemaXellerate™ Phase 1 Trial

    19 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/19/2984018/0/en/Regen-BioPharma-Inc-Expands-Vision-for-Phase-1-Clinical-Trial-of-HemaXellerate.html

    GLOBENEWSWIRE
    19 Nov 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search